Cue Biopharma (CUE) Payables (2017 - 2025)
Cue Biopharma (CUE) posted Payables of $200000.0 for Q4 2025, down 91.48% sequentially from $2.3 million in Q3 2025, and down 92.92% YoY from $2.8 million in Q4 2024.
Cue Biopharma (CUE) Payables (2017 - 2025) Analysis & Trends
Cue Biopharma has reported Payables for 9 years, with the latest figure at $200000.0 in Q4 2025.
- Quarterly Payables fell 92.92% year-over-year to $200000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $200000.0 (down 92.92% YoY) and the FY2025 annual result came in at $200000.0, down 92.92% from the prior year.
- Payables slipped to $200000.0 in Q4 2025 per CUE's latest filing, from $2.3 million in the prior quarter.
- Over five years, Payables peaked at $6.5 million in Q3 2024 and troughed at $200000.0 in Q4 2025.
- A 5-year average of $2.9 million and a median of $2.6 million in 2021 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables soared 161.05% in 2024, then slumped 92.92% in 2025.
- Over 5 years, Payables stood at $2.6 million in 2021, then grew by 5.42% to $2.7 million in 2022, then advanced by 28.19% to $3.5 million in 2023, then fell by 19.37% to $2.8 million in 2024, then plunged by 92.92% to $200000.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $200000.0, $2.3 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | 3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 6.47 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Jun 30, 2021 | 2.99 Mn |
| Mar 31, 2021 | 2.52 Mn |